Purple Biotech Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Purple Biotech in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Purple Biotech.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24
Strong Buy	3	3	2	2	2
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	3	3	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $33	Strong Buy	Reiterates	$33	+4,290.63%	Nov 15, 2024
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $8 → $33	Strong Buy	Maintains	$8 → $33	+4,290.63%	Sep 20, 2024
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $200 → $160	Strong Buy	Maintains	$200 → $160	+21,187.92%	Aug 19, 2024
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $200	Strong Buy	Reiterates	$200	+26,509.90%	Jul 11, 2024
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $200	Strong Buy	Reiterates	$200	+26,509.90%	May 21, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.